Clinical trial
A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children…
NCT00186927 · St. Jude Children's Research Hospital, Other · Suspended
Key facts
| NCT number | NCT00186927 |
|---|---|
| Title | A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers |
| Official title | A Phase I Study of Unmodified Live Intranasal Sendai Virus Vaccine in Children and Toddlers: Assessment of Safety and Immunogenicity |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Suspended |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Parainfluenza, Respiratory Viral Infections |
| Intervention type | Biological |
| Interventions | Sendai virus vaccine |
| Enrollment | 54 |
| Start date | May 5, 2005 |
| Primary completion | Jan 1, 2026 |
| Completion | Jan 1, 2027 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 19, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: